Back to search
ALK Fusion Protein Expression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which ALK Fusion Protein Expression trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which ALK Fusion Protein Expression trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial studies how well brigatinib works in treating patients with ALK and ROS1 gene alterations and solid cancers that have spread to nearby tissu…
This randomized, active-controlled, multicenter, open-label, Phase II study is designed to evaluate the efficacy and safety of ensatinib compared with Platinum-…